KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Net Income (2016 - 2025)

Historic Net Income for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $908.0 million.

  • Cme's Net Income fell 52.59% to $908.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year increase of 860.12%. This contributed to the annual value of $3.5 billion for FY2024, which is 928.65% up from last year.
  • Latest data reveals that Cme reported Net Income of $908.0 million as of Q3 2025, which was down 52.59% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, Cme's Net Income registered a high of $1.0 billion during Q2 2025, and its lowest value of $510.6 million during Q2 2021.
  • Its 5-year average for Net Income is $787.9 million, with a median of $814.6 million in 2023.
  • As far as peak fluctuations go, Cme's Net Income skyrocketed by 12510.33% in 2021, and later plummeted by 2663.28% in 2022.
  • Over the past 5 years, Cme's Net Income (Quarter) stood at $625.2 million in 2021, then rose by 2.03% to $637.9 million in 2022, then grew by 27.7% to $814.6 million in 2023, then rose by 7.37% to $874.6 million in 2024, then rose by 3.82% to $908.0 million in 2025.
  • Its Net Income was $908.0 million in Q3 2025, compared to $1.0 billion in Q2 2025 and $956.2 million in Q1 2025.